Millions of people living with lung conditions face heightened health risks this winter due to persistent wet weather and the ...
A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research from The Jackson Laboratory (JAX). Published in Cell Reports, the study found ...
Research published in ACS Central Science could help healthcare professionals non-invasively diagnose bacterial infections, using breath-based tests.
New research is examining what happens in the lungs after severe respiratory infections.
Climate change might intensify dust storms, causing more respiratory health risks.
Respiratory illnesses such as COVID-19 and influenza are usually thought of as short-term infections that cause fever, cough, and fatigue. Most people recover within days or weeks. However, scientists ...
A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists discovered that serious viral infections can alter immune cells in the ...
The dipeptidyl peptidase-1 (DPP1) inhibitor brensocatib became the first licensed therapy for bronchiectasis in the USA and Europe in 2025,1 based on the phase 3 ASPEN trial showing an approximate 20% ...
A UVA Health study finds severe viral infections can prime the lungs for cancer, but vaccination appears to reduce that risk.